Cargando…

Digital gene expression profiling analysis and its application in the identification of genes associated with improved response to neoadjuvant chemotherapy in breast cancer

BACKGROUND: This study aimed to screen sensitive biomarkers for the efficacy evaluation of neoadjuvant chemotherapy in breast cancer. METHODS: In this study, Illumina digital gene expression sequencing technology was applied and differentially expressed genes (DEGs) between patients presenting patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaozhen, Jin, Gan, Qian, Jiacheng, Yang, Hongjian, Tang, Hongchao, Meng, Xuli, Li, Yongfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5914024/ https://www.ncbi.nlm.nih.gov/pubmed/29685151 http://dx.doi.org/10.1186/s12957-018-1380-z

Ejemplares similares

RNA Sequencing Uncovers Molecular Mechanisms Underlying Pathological Complete Response to Chemotherapy in Patients with Operable Breast Cancer
por: Li, Yongfeng, et al.
Publicado: (2017)

Predicting Axillary Response in Hormone Receptor-Positive Breast Cancer after Neoadjuvant Chemotherapy Using Real-World Data
por: Qiu, Jie, et al.
Publicado: (2022)

Risk factors for the development of severe breast cancer-related lymphedema: a retrospective cohort study
por: Liu, Xiaozhen, et al.
Publicado: (2023)

Integrative landscape analysis of prognostic model biomarkers and immunogenomics of disulfidptosis-related genes in breast cancer based on LASSO and WGCNA analyses
por: Liu, Shuyan, et al.
Publicado: (2023)

Identification of Ferroptosis-Related Prognostic Signature and Subtypes Related to the Immune Microenvironment for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Xu, Yuhao, et al.
Publicado: (2022)

Z-Guggulsterone Induces Cell Cycle Arrest and Apoptosis by Targeting the p53/CCNB1/PLK1 Pathway in Triple-Negative Breast Cancer
por: Wu, Yihao, et al.
Publicado: (2023)

Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy
por: Sahni, Sumit, et al.
Publicado: (2023)

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
por: Wu, Jin, et al.
Publicado: (2022)

Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
por: Zheng, Yiwen, et al.
Publicado: (2023)

NMR-Based Metabolomics Analysis Predicts Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
por: He, Xiangming, et al.
Publicado: (2021)

Predictive value of DNA repair gene expression for response to neoadjuvant chemotherapy in breast cancer
por: Kneubil, M.C., et al.
Publicado: (2022)

Breast cancer organoids and their applications for precision cancer immunotherapy
por: Guan, Dandan, et al.
Publicado: (2023)

Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional Validation
por: Vishnubalaji, Radhakrishnan, et al.
Publicado: (2022)

Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway
por: Xia, Wenjie, et al.
Publicado: (2023)

Advances in Imaging in Evaluating the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
por: Kong, Xianshu, et al.
Publicado: (2022)

Regional methylome profiling reveals dynamic epigenetic heterogeneity and convergent hypomethylation of stem cell quiescence-associated genes in breast cancer following neoadjuvant chemotherapy
por: Luo, Yumei, et al.
Publicado: (2019)

Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
por: Nolen, Brian M, et al.
Publicado: (2008)

Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
por: Xing, Ai-Yan, et al.
Publicado: (2021)

Assessment of the Predictive Role of Serum Lipid Profiles in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Qu, Fanli, et al.
Publicado: (2020)

A Decision-Making Supporting Prediction Method for Breast Cancer Neoadjuvant Chemotherapy
por: Song, Dong, et al.
Publicado: (2021)

Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression
por: Denisov, Evgeny V., et al.
Publicado: (2014)

A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
por: Zheng, Tianzhi, et al.
Publicado: (2019)

Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy
por: Zhao, Yanding, et al.
Publicado: (2020)

Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Omar, Mohamed, et al.
Publicado: (2023)

Application of next-generation sequencing in resistance genes of neoadjuvant chemotherapy for esophageal cancer
por: Liu, Jizhao, et al.
Publicado: (2020)

LncRNA AWPPH as a prognostic predictor in human cancers in Chinese population: evidence from meta-analysis
por: Li, Yongfeng, et al.
Publicado: (2021)

The Effect of the Leptin and Leptin Receptor Expression on the Efficacy of Neoadjuvant Chemotherapy in Breast Cancer
por: Kong, Yan, et al.
Publicado: (2019)

Identification of an lncRNA-miRNA-mRNA interaction mechanism in breast cancer based on bioinformatic analysis
por: Zhang, Yuhan, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study
por: Shao, Zhiying, et al.
Publicado: (2016)

Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy
por: Stoll, Gautier, et al.
Publicado: (2014)

Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling
por: Shen, Lu-Yan, et al.
Publicado: (2015)

Genomic landscape and immune-related gene expression profiling of epithelial ovarian cancer after neoadjuvant chemotherapy
por: Lodewijk, I., et al.
Publicado: (2022)

New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
por: An, Junsha, et al.
Publicado: (2021)

Machine Learning-Based Radiomics Nomogram Using Magnetic Resonance Images for Prediction of Neoadjuvant Chemotherapy Efficacy in Breast Cancer Patients
por: Chen, Shujun, et al.
Publicado: (2020)

Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review
por: Xu, Weilin, et al.
Publicado: (2020)

Radiological assessment of neoadjuvant chemotherapy in breast cancer
por: Ollivier, Liliane
Publicado: (2015)

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
por: Wang, Huan, et al.
Publicado: (2020)

Prediction of neoadjuvant chemotherapy response in breast cancer
por: Myllys, Maiju
Publicado: (2021)

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer
por: Ding, Yuqin, et al.
Publicado: (2020)

Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Meyer, Braydon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8aseokhvu25lg048oqu98so8f6